CGRP-REZEPTOR-ANTAGONISTEN
Patent europeic · EP3368526 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3368526
- Numer da la dumonda
- EP16808804
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 28-10-2016
- Publitgà
- 05-09-2018
- Concedì
- 25-12-2019
- La protecziun finescha il pli tard
- 27-10-2036
- Proxima taxa annuala scadenta
- 31-10-2026
- Classas IPC
- C07D 401/14 (2006.01)A61P 25/00 (2006.01)A61P 25/06 (2006.01)A61P 29/00 (2006.01)A61K 31/4709 (2006.01)
- Prioritad
- GB 201519194 30.10.2015
- Dumonda PCT
- PCT/IB2016/056519 28.10.2016
- Publicaziun PCT
- WO2017/072723 04.05.2017
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-11-2025
Midada
Published in Swissreg on 01.11.2025
- 01-11-2024
Midada
Published in Swissreg on 01.11.2024
- 30-10-2024
Adressa dal possessur midada
- Owner
- Heptares Therapeutics Limited, Granta Park, Great Abington, Cambridge CB21 6DG, United Kingdom → Nxera Pharma UK Limited, Granta Park, Great Abington, Cambridge CB21 6DG, United Kingdom
Published in Swissreg on 30.10.2024
- 26-01-2024
Midada
Published in Swissreg on 26.01.2024
- 01-11-2022
Midada
Published in Swissreg on 01.11.2022
- 22-02-2020
Represchentant inscrit
- Representative
- TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly
Published in Swissreg on 22.02.2020
- 25-12-2019
Concedì
Published in Swissreg on 25.12.2019
Partidas
Represchentant
Inventur
Cambridge CB21 6DG, GB
Cambridge CB21 6DG, GB
Cambridge CB21 6DG, GB
Cambridge CB21 6DG, GB
Cambridge CB21 6DG, GB
Cambridge CB21 6DG, GB
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.